Explore the words cloud of the MetAccembly project. It provides you a very rough idea of what is the project "MetAccembly" about.
The following table provides information about the project.
Coordinator |
UNIVERSITAT DE GIRONA
Organization address contact info |
Coordinator Country | Spain [ES] |
Project website | https://ferranfeixas.wordpress.com/ |
Total cost | 158˙121 € |
EC max contribution | 158˙121 € (100%) |
Programme |
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility) |
Code Call | H2020-MSCA-IF-2014 |
Funding Scheme | MSCA-IF-EF-ST |
Starting year | 2015 |
Duration (year-month-day) | from 2015-05-01 to 2017-04-30 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | UNIVERSITAT DE GIRONA | ES (GIRONA) | coordinator | 158˙121.00 |
Transition metals (TMs) are found in the core of several phenomena such as catalysis, self-assembly and (bio)molecular recognition and are directly involved in a number of diseases that span from cancer to neurodegenerative disorders. The presence of metal ions or metallocofactors in the active site of enzymes remarkably enhances the diversity of functions displayed by these biomolecules. TMs are also basic elements of approved drugs and MRI contrast agents playing a key role in biomolecular recognition. Metals in biology are extremely important but are also extremely complex to characterize and its role in processes such as protein assembly and molecular recognition is still poorly understood. These important biological processes take place in a broad range of time scales that span from ultrafast bond vibrations occurring in femtoseconds to slow conformational changes that require milliseconds to even seconds to be completed. The long-term goal of this project is to understand how and where these interactions occur. In the first goal of this proposal, we aim to develop a novel computational method (extended aMD) based on accelerated molecular dynamics that can be used to gain insights into metal-directed assembly, molecular recognition and biocatalysis at a reasonable computational cost. The second research goal of the proposal is to combine state of the art techniques of electronic structure with the new computational method to gain insight into the TMs-driven assembly, biomolecular recognition and catalysis mechanism of amyloid formation, inhibition and catalytic power. Extended aMD will be a versatile method that in principle will be applicable to describe assembly of large biomolecules. Applications in the field of enzyme design and drug discovery are expected in the long-term. After the execution of this project, the applicant will acquire a wider perspective on the field, as well as reached a position of full independence and professional maturity.
year | authors and title | journal | last update |
---|---|---|---|
2015 |
Yinglong Miao, Ferran Feixas, Changsun Eun, J. Andrew McCammon Accelerated molecular dynamics simulations of protein folding published pages: 1536-1549, ISSN: 0192-8651, DOI: 10.1002/jcc.23964 |
Journal of Computational Chemistry 36/20 | 2019-07-24 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "METACCEMBLY" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "METACCEMBLY" are provided by the European Opendata Portal: CORDIS opendata.
Multiparametric imaging of glioblastoma tumour heterogeneity for supporting treatment decisions and accurate prognostic estimation
Read MoreDeciphering intrarenal communication to unvail mechanisms of chronic kidney diseases
Read MoreARGONAUT: from the synthesis of gAnglioside tumouR antiGens to a platfOrm for caNcer Active immUnoTherapy
Read More